Ketorolac Trometamol Kent Pharma Uk

Ketorolac trometamol, the active ingredient in Ketorolac Trometamol Kent Pharma Uk, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an injectable solution for intramuscular and intravenous use. It provides short‑term relief of moderate to severe pain, especially after surgery, in adult patients.

GNH USA supplies Ketorolac Trometamol Kent Pharma Uk as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Ketorolac trometamol is an NSAID used for acute pain conditions where rapid analgesia is required.

- Post‑operative pain: provides short‑term relief of moderate to severe pain after surgical procedures. - Acute musculoskeletal pain: reduces pain and inflammation following injury or trauma. - Dental pain: alleviates severe pain after dental extractions or other oral surgeries.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Nausea - Headache - Dizziness - Injection site pain

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulceration - Acute renal failure - Severe allergic reaction (anaphylaxis)

Ketorolac trometamol requires careful assessment of patient risk factors before use.

- Renal function: evaluate baseline kidney function and avoid in severe impairment. - Bleeding risk: avoid in patients with active peptic ulcer disease or recent major surgery. - Cardiovascular disease: use cautiously in patients with coronary artery disease or hypertension. - Pregnancy: avoid unless benefits clearly outweigh potential risks. - Concomitant NSAIDs: do not combine with other NSAIDs or COX‑2 inhibitors. - Store at below 25°C: keep in the original container, protect from moisture and light.

Ketorolac trometamol can interact with several drug classes, altering safety or efficacy.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Other NSAIDs or COX‑2 inhibitors: additive gastrointestinal toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may reduce renal perfusion and function. - Diuretics: heightened risk of renal impairment. - Lithium: ketorolac can raise serum lithium concentrations, requiring monitoring.